FDA Warns About Serious Side Effects Of Multiple Sclerosis Drug

The FDA is warning consumers about the risk of rare but serious cases of stroke and tears in the lining of arteries in the head and neck associated with multiple sclerosis drug Lemtrada, chemically known as Alemtuzumab. These problems can lead to permanent disability and even death.

from RTT - Biotech https://ift.tt/2reL0m6
via IFTTT